| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypercapnia | D006935 | 5 associated lipids |
| Aortic Aneurysm, Abdominal | D017544 | 5 associated lipids |
| Respiration Disorders | D012120 | 5 associated lipids |
| Glomerulonephritis, Membranous | D015433 | 6 associated lipids |
| Coronary Stenosis | D023921 | 6 associated lipids |
| Purpura, Thrombotic Thrombocytopenic | D011697 | 6 associated lipids |
| Sneezing | D012912 | 6 associated lipids |
| Intermittent Claudication | D007383 | 6 associated lipids |
| Thrombophilia | D019851 | 6 associated lipids |
| Thromboembolism | D013923 | 6 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mancini F et al. | Time since menopause does not affect plasma viscosity, plasma thromboxane levels and Doppler findings. | 2005 | Gynecol. Endocrinol. | pmid:16019357 |
| Mancini F et al. | Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers. | 2005 | Gynecol. Endocrinol. | pmid:16019365 |
| Michibayashi T | Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways. | 2005 | J. Atheroscler. Thromb. | pmid:16020916 |
| Svenstrup Poulsen T et al. | A critical appraisal of the phenomenon of aspirin resistance. | 2005 | Cardiology | pmid:16020925 |
| Walsh DS et al. | Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury. | 2005 | J. Surg. Res. | pmid:16045935 |
| Rodrigue ME et al. | Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. | 2005 | Can. J. Physiol. Pharmacol. | pmid:16049546 |
| Esser R et al. | Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. | 2005 | Br. J. Pharmacol. | pmid:15655513 |
| Sullivan JC et al. | Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. | 2005 | Hypertension | pmid:15699443 |
| Munsterhjelm E et al. | Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. | 2005 | Acta Anaesthesiol Scand | pmid:15954969 |
| Vangroenweghe F et al. | Effect of carprofen treatment following experimentally induced Escherichia coli mastitis in primiparous cows. | 2005 | J. Dairy Sci. | pmid:15956299 |
| Wakamoto S et al. | Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. | 2005 | Artif Cells Blood Substit Immobil Biotechnol | pmid:15960075 |
| Al Kadi H et al. | A prospective, longitudinal study of the renin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birthweight. | 2005 | Hum. Reprod. | pmid:16006463 |
| Beretta C et al. | COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. | 2005 | Pharmacol. Res. | pmid:15939622 |
| Klein Gunnewiek JM et al. | The influence of acetylsalicylic acid intake by healthy volunteers on duplicate PFA-100 measurements. | 2005 | Blood Coagul. Fibrinolysis | pmid:15970717 |
| Visioli F et al. | Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. | 2005 | Eur J Nutr | pmid:15309433 |
| Jin YR et al. | Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15328379 |
| Jin YR et al. | An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. | 2005 | Basic Clin. Pharmacol. Toxicol. | pmid:16128910 |
| Jermany J et al. | Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects. | 2005 | J Clin Pharmacol | pmid:16172182 |
| Persico N et al. | Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients. | 2005 | Ultrasound Obstet Gynecol | pmid:16184506 |
| Perini JA et al. | Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. | 2005 | Clin. Pharmacol. Ther. | pmid:16198655 |
| Davì G et al. | Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15472127 |
| Maree AO et al. | Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. | 2005 | J. Am. Coll. Cardiol. | pmid:16198840 |
| Kataoka M et al. | A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:16192456 |
| Munsterhjelm E et al. | Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. | 2005 | Anesthesiology | pmid:16192763 |
| Trebino CE et al. | Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. | 2005 | J. Biol. Chem. | pmid:15722356 |
| Awad AS et al. | Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats. | 2005 | Am. J. Hypertens. | pmid:15831366 |
| De Candia E et al. | Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. | 2005 | Int. J. Cardiol. | pmid:15837078 |
| Capone ML et al. | Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. | 2005 | J. Am. Coll. Cardiol. | pmid:15837265 |
| Oliveira RL et al. | Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. | 2005 | Int. J. Cardiol. | pmid:15771927 |
| Cryer B et al. | Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. | 2005 | Clin Ther | pmid:15811481 |
| Chang Y et al. | Mechanisms involved in the antiplatelet activity of ketamine in human platelets. | 2004 Nov-Dec | J. Biomed. Sci. | pmid:15591773 |
| Barrière G et al. | PHGPx overexpression induces an increase in COX-2 activity in colon carcinoma cells. | 2004 May-Jun | Anticancer Res. | pmid:15274299 |
| Persico N et al. | Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients. | 2004 | Gynecol. Endocrinol. | pmid:15726916 |
| He J et al. | Treatment of unstable angina pectoris with modified nuan gan jian--a report of 33 cases. | 2004 | J Tradit Chin Med | pmid:15688691 |
| Lam AN et al. | Effect of red clover isoflavones on cox-2 activity in murine and human monocyte/macrophage cells. | 2004 | Nutr Cancer | pmid:15456640 |
| Moriguchi A et al. | Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. | 2004 | J. Pharmacol. Exp. Ther. | pmid:14634048 |
| Barbieri SS et al. | Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. | 2004 | Free Radic. Biol. Med. | pmid:15203187 |
| Kojima F et al. | Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. | 2004 | Arthritis Res. Ther. | pmid:15225371 |
| Farndale RW et al. | Measurement of platelet arachidonic acid metabolism. | 2004 | Methods Mol. Biol. | pmid:15226540 |
| Barbara J et al. | Inhaled cornstarch glove powder increases latex-induced airway hyper-sensitivity in guinea-pigs. | 2004 | Clin. Exp. Allergy | pmid:15196289 |
| Wu KJ et al. | [Detection of thromboxane B2, 6-keto-prostaglandin F1alpha and anticardiolipin antibody in patients with obstructive sleep apnea-hypopnea syndrome]. | 2004 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:15196341 |
| Van Ryn J et al. | Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers. | 2004 | J Clin Pharmacol | pmid:15199082 |
| de La Puerta Vázquez R et al. | Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. | 2004 | Metab. Clin. Exp. | pmid:14681843 |
| von Aulock S et al. | Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. | 2004 | J. Pharmacol. Exp. Ther. | pmid:14610236 |
| Wang MS et al. | [The effects of lupus anticoagulant on pulmonary thromboembolism]. | 2004 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:15634384 |
| Franz KB | A functional biological marker is needed for diagnosing magnesium deficiency. | 2004 | J Am Coll Nutr | pmid:15637224 |
| Cardoni RL and Antúnez MI | Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. | 2004 | Mediators Inflamm. | pmid:15545053 |
| Wu JX et al. | Changes in somatostatin receptor expression of the pancreas and effectiveness of octreotide in rats with acute necrotizing pancreatitis. | 2004 | Chin J Dig Dis | pmid:15612670 |
| Véricel E et al. | Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. | 2004 | Diabetes | pmid:15047620 |
| Yugar-Toledo JC et al. | Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. | 2004 | Chest | pmid:15006938 |